[Federal Register Volume 66, Number 229 (Wednesday, November 28, 2001)]
[Notices]
[Page 59445]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-29523]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel.
    Date: January 16-17, 2002.
    Time: 7:30 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Pickwick Hotel and Suites, 1023 20th Street South, 
Birmingham, AL 35294.
    Contact Person: William E. Elzinga, Ph.D., Scientific Review 
Administrator, Review Branch, DEA, NIDDK, Room 747, 6707 Democracy 
Boulevard, National Institutes of Health, Bethesda, MD 20892-6600, 
(301) 594-8895.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS).


    Dated: November 19, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-29523 Filed 11-27-01; 8:45 am]
BILLING CODE 4140-01-M